Biogen Inc (BIIB)

Index:

Nasdaq 100

$ 177.35
   
  • Change Today:
    $1.33
  • 52 Week High: $201.18
  • 52 Week Low: $118.84
  • Currency: US Dollars
  • Shares Issued: 146.80m
  • Volume: 1,239,458
  • Market Cap: $26,035m
  • RiskGrade: 259

Latest ShareCast News

Biogen to buy Apellis Pharmaceuticals in $5.6bn deal

By Michele Maatouk

Date: Tuesday 31 Mar 2026

(Sharecast News) - Shares in Apellis Pharmaceuticals rocketed on Tuesday after it agreed to be bought by Biogen in a $5.6bn deal.

Biogen ups forecasts despite weak Alzheimer's drug sales

By Abigail Townsend

Date: Wednesday 20 Oct 2021

(Sharecast News) - Biogen raised its full-year earnings guidance on Wednesday, despite weak sales of breakthrough Alzheimer's drug Aduhelm.

Biogen shares soar as FDA approves Alzheimer's drug

By Abigail Townsend

Date: Tuesday 08 Jun 2021

(Sharecast News) - Shares in Biogen closed nearly 40% higher after the biotech's breakthrough Alzheimer's drug received regulatory approval in the US.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Biogen Inc Market Data

Currency US Dollars
Share Price $ 177.35
Change Today $ 1.33
% Change 0.76 %
52 Week High $201.18
52 Week Low $118.84
Volume 1,239,458
Shares Issued 146.80m
Market Cap $26,035m
RiskGrade 259

What The Brokers Say

Strong Buy 8
Buy 6
Neutral 19
Sell 1
Strong Sell 0
Total 34
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 17-Apr-2026

Time Volume / Share Price
15:59 300 @ $177.38
15:59 200 @ $177.38
15:59 384 @ $177.38
15:59 100 @ $177.34
15:59 100 @ $177.34

Top of Page